These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34685701)

  • 1. Regulation of Tumor Metabolism and Extracellular Acidosis by the TIMP-10-CD63 Axis in Breast Carcinoma.
    Najy AJ; Jung YS; Kim S; Fridman R; Kim HC
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.
    Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L
    J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.
    Müller V; Riethdorf S; Rack B; Janni W; Fasching PA; Solomayer E; Aktas B; Kasimir-Bauer S; Zeitz J; Pantel K; Fehm T;
    Breast Cancer Res; 2011 Jul; 13(4):R71. PubMed ID: 21745383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAIX-Mediated Control of LIN28/
    Gibadulinova A; Bullova P; Strnad H; Pohlodek K; Jurkovicova D; Takacova M; Pastorekova S; Svastova E
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells.
    D'Angelo RC; Liu XW; Najy AJ; Jung YS; Won J; Chai KX; Fridman R; Kim HR
    Mol Cancer Res; 2014 Sep; 12(9):1324-33. PubMed ID: 24895412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy.
    Warner RB; Najy AJ; Jung YS; Fridman R; Kim S; Kim HC
    Sci Rep; 2020 Feb; 10(1):2099. PubMed ID: 32034211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma.
    Duch P; Díaz-Valdivia N; Ikemori R; Gabasa M; Radisky ES; Arshakyan M; Gea-Sorlí S; Mateu-Bosch A; Bragado P; Carrasco JL; Mori H; Ramírez J; Teixidó C; Reguart N; Fillat C; Radisky DC; Alcaraz J
    Matrix Biol; 2022 Aug; 111():207-225. PubMed ID: 35787446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein.
    Jung KK; Liu XW; Chirco R; Fridman R; Kim HR
    EMBO J; 2006 Sep; 25(17):3934-42. PubMed ID: 16917503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.
    Aaberg-Jessen C; Sørensen MD; Matos ALSA; Moreira JM; Brünner N; Knudsen A; Kristensen BW
    BMC Cancer; 2018 Mar; 18(1):270. PubMed ID: 29523123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAF (V600E) mutation status and together with hypoxia-related proteins predicts aggressive behavior.
    Ilie MI; Lassalle S; Long-Mira E; Hofman V; Zangari J; Bénaim G; Bozec A; Guevara N; Haudebourg J; Birtwisle-Peyrottes I; Santini J; Brest P; Hofman P
    Virchows Arch; 2013 Sep; 463(3):437-44. PubMed ID: 23893334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of TIMP1, CD63, and β1-Integrin and the Functional Impact of Their Interaction in Cancer.
    Justo BL; Jasiulionis MG
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
    Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
    Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells.
    Mboge MY; Chen Z; Khokhar D; Wolff A; Ai L; Heldermon CD; Bozdag M; Carta F; Supuran CT; Brown KD; McKenna R; Frost CJ; Frost SC
    Biochem J; 2019 May; 476(10):1497-1513. PubMed ID: 31072911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial.
    Peña C; Lathia C; Shan M; Escudier B; Bukowski RM
    Clin Cancer Res; 2010 Oct; 16(19):4853-63. PubMed ID: 20651059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.
    Najy AJ; Dyson G; Jena BP; Lin CY; Kim HR
    Am J Physiol Cell Physiol; 2016 Feb; 310(4):C293-304. PubMed ID: 26157007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
    Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
    Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.
    Güttler A; Theuerkorn K; Riemann A; Wichmann H; Kessler J; Thews O; Bache M; Vordermark D
    Oncol Rep; 2019 Apr; 41(4):2585-2594. PubMed ID: 30720123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.
    Chiche J; Ilc K; Laferrière J; Trottier E; Dayan F; Mazure NM; Brahimi-Horn MC; Pouysségur J
    Cancer Res; 2009 Jan; 69(1):358-68. PubMed ID: 19118021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.